LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11,000 | -72.5% | 161 | -65.0% | 0.00% | – |
Q3 2022 | $40,000 | +5.3% | 460 | +6.7% | 0.00% | – |
Q2 2022 | $38,000 | -11.6% | 431 | +11.7% | 0.00% | – |
Q1 2022 | $43,000 | -14.0% | 386 | +19.1% | 0.00% | – |
Q4 2021 | $50,000 | +47.1% | 324 | +34.4% | 0.00% | – |
Q3 2021 | $34,000 | +88.9% | 241 | +74.6% | 0.00% | – |
Q2 2021 | $18,000 | +125.0% | 138 | +150.9% | 0.00% | – |
Q1 2021 | $8,000 | -99.5% | 55 | -99.7% | 0.00% | -100.0% |
Q3 2019 | $1,566,000 | -46.5% | 15,731 | -38.6% | 0.01% | -50.0% |
Q2 2019 | $2,925,000 | -57.4% | 25,625 | -53.1% | 0.02% | -55.6% |
Q1 2019 | $6,866,000 | -12.3% | 54,615 | -5.3% | 0.04% | -21.7% |
Q4 2018 | $7,830,000 | -44.3% | 57,701 | +12.6% | 0.05% | -33.3% |
Q3 2018 | $14,064,000 | +1.4% | 51,237 | -23.5% | 0.07% | -1.4% |
Q2 2018 | $13,872,000 | +40.9% | 66,958 | +12.4% | 0.07% | +37.3% |
Q1 2018 | $9,843,000 | +14.3% | 59,596 | -5.2% | 0.05% | +21.4% |
Q4 2017 | $8,612,000 | +50.5% | 62,896 | +49.6% | 0.04% | +40.0% |
Q3 2017 | $5,724,000 | -15.2% | 42,042 | -24.4% | 0.03% | +57.9% |
Q2 2017 | $6,750,000 | +113.1% | 55,600 | +85.8% | 0.02% | +5.6% |
Q1 2017 | $3,167,000 | -38.2% | 29,927 | -39.7% | 0.02% | -37.9% |
Q4 2016 | $5,125,000 | -0.7% | 49,630 | -1.8% | 0.03% | -9.4% |
Q3 2016 | $5,159,000 | -14.4% | 50,550 | 0.0% | 0.03% | -17.9% |
Q2 2016 | $6,029,000 | -6.8% | 50,550 | -16.3% | 0.04% | -7.1% |
Q1 2016 | $6,468,000 | -2.7% | 60,396 | -1.5% | 0.04% | +2.4% |
Q4 2015 | $6,645,000 | +27.8% | 61,294 | +1.0% | 0.04% | +24.2% |
Q3 2015 | $5,199,000 | -2.4% | 60,700 | +15.0% | 0.03% | +6.5% |
Q2 2015 | $5,328,000 | -4.4% | 52,800 | -27.0% | 0.03% | -3.1% |
Q1 2015 | $5,575,000 | +21.7% | 72,300 | -16.0% | 0.03% | +18.5% |
Q4 2014 | $4,581,000 | +13.2% | 86,100 | 0.0% | 0.03% | +12.5% |
Q3 2014 | $4,046,000 | -24.6% | 86,100 | 0.0% | 0.02% | -20.0% |
Q2 2014 | $5,363,000 | -15.1% | 86,100 | -8.3% | 0.03% | -18.9% |
Q1 2014 | $6,316,000 | -9.0% | 93,900 | -28.8% | 0.04% | 0.0% |
Q4 2013 | $6,938,000 | +43.3% | 131,900 | +17.9% | 0.04% | +42.3% |
Q3 2013 | $4,843,000 | – | 111,900 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |